Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Buildings: 2013-2014

Historic Buildings for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Dec 2014 value amounting to $67.8 million.

  • Amphastar Pharmaceuticals' Buildings rose 5.71% to $67.8 million in Q2 2015 from the same period last year, while for Jun 2015 it was $67.8 million, marking a year-over-year increase of 5.71%. This contributed to the annual value of $67.8 million for FY2014, which is 15.05% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Buildings of $67.8 million as of FY2014, which was up 15.05% from $58.9 million recorded in FY2013.
  • Amphastar Pharmaceuticals' Buildings' 5-year high stood at $67.8 million during FY2014, with a 5-year trough of $58.9 million in FY2013.
  • In the last 2 years, Amphastar Pharmaceuticals' Buildings had a median value of $63.3 million in 2013 and averaged $63.3 million.
  • Data for Amphastar Pharmaceuticals' Buildings shows a peak YoY grew of 15.05% (in 2014) over the last 5 years.
  • Amphastar Pharmaceuticals' Buildings (Yearly) stood at $58.9 million in 2013, then climbed by 15.05% to $67.8 million in 2014.